Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Short Interest Up 3,878.9% in August

Posted by Renee Jackson on Sep 10th, 2026

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 756 shares, a growth of 3,878.9% from the August 15th total of 19 shares. Based on an average trading volume of 3,423 shares, the short-interest ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. UBS Group cut shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a report on Tuesday, August 11th. Morgan Stanley began coverage on Carl Zeiss Meditec in a report on Wednesday, September 2nd. They set an “underweight” rating for the company. Finally, Zacks Research cut Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 11th. Two investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Strong Sell”.

View Our Latest Stock Analysis on CZMWY

Carl Zeiss Meditec Trading Up 0.5%

Shares of OTCMKTS CZMWY traded up $0.19 during mid-day trading on Thursday, reaching $35.85. 1,132 shares of the company’s stock were exchanged, compared to its average volume of 4,242. The firm has a 50-day moving average price of $34.91 and a two-hundred day moving average price of $31.68. Carl Zeiss Meditec has a 52 week low of $26.65 and a 52 week high of $55.94.

About Carl Zeiss Meditec

(Get Free Report)

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.